Stefano Ferrari - Net Worth and Insider Trading
Stefano Ferrari Net Worth
The estimated net worth of Stefano Ferrari is at least $41,888 dollars as of 2024-09-20. Stefano Ferrari is the Director of Matinas BioPharma Holdings Inc and owns about 11,111 shares of Matinas BioPharma Holdings Inc (MTNB) stock worth over $41,888. Details can be seen in Stefano Ferrari's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stefano Ferrari has not made any transactions after 2017-09-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stefano Ferrari
Stefano Ferrari Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stefano Ferrari owns 1 companies in total, including Matinas BioPharma Holdings Inc (MTNB) .
Click here to see the complete history of Stefano Ferrari’s form 4 insider trades.
Insider Ownership Summary of Stefano Ferrari
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
MTNB | Matinas BioPharma Holdings Inc | 2017-09-07 | director |
Stefano Ferrari Latest Holdings Summary
Stefano Ferrari currently owns a total of 1 stock. Stefano Ferrari owns 11,111 shares of Matinas BioPharma Holdings Inc (MTNB) as of September 7, 2017, with a value of $41,888.
Latest Holdings of Stefano Ferrari
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MTNB | Matinas BioPharma Holdings Inc | 2017-09-07 | 11,111 | 3.77 | 41,888 |
Holding Weightings of Stefano Ferrari
Stefano Ferrari Form 4 Trading Tracker
According to the SEC Form 4 filings, Stefano Ferrari has made a total of 0 transactions in Matinas BioPharma Holdings Inc (MTNB) over the past 5 years. The most-recent trade in Matinas BioPharma Holdings Inc is the acquisition of 100 shares on September 7, 2017, which cost Stefano Ferrari around $6,200.
Insider Trading History of Stefano Ferrari
- 1
Stefano Ferrari Trading Performance
GuruFocus tracks the stock performance after each of Stefano Ferrari's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stefano Ferrari is 1.46%. GuruFocus also compares Stefano Ferrari's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stefano Ferrari within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stefano Ferrari's insider trading performs compared to the benchmark.
Performance of Stefano Ferrari
Stefano Ferrari Ownership Network
Stefano Ferrari Owned Company Details
What does Matinas BioPharma Holdings Inc do?
Who are the key executives at Matinas BioPharma Holdings Inc?
Stefano Ferrari is the director of Matinas BioPharma Holdings Inc. Other key executives at Matinas BioPharma Holdings Inc include Chief Business Officer Thomas Hoover , director & Chief Executive Officer Jerome D Jabbour , and Chief Financial Officer Keith A Kucinski .
Matinas BioPharma Holdings Inc (MTNB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Matinas BioPharma Holdings Inc (MTNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Matinas BioPharma Holdings Inc (MTNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Matinas BioPharma Holdings Inc (MTNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Matinas BioPharma Holdings Inc Insider Transactions
Stefano Ferrari Mailing Address
Above is the net worth, insider trading, and ownership report for Stefano Ferrari. You might contact Stefano Ferrari via mailing address: C/o Matinas Biopharma Holdings, Inc., 1545 Route 206 South, Suite 302, Bedminster Nj 07921.